Targeted Cancer Therapies
Pazopanib
BPT-1210 · Tablet
What is it used for?
Blocks VEGF and other kinase pathways involved in tumor blood-vessel formation and growth. Used for advanced kidney cancer and selected advanced soft-tissue sarcomas after prior chemotherapy.
- Dosage form
- Tablet
- Listed strengths
- 200 mg
- Listed pack size
- 60's
- Mechanism
- Multikinase inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Advanced renal cell carcinoma
- Selected previously treated advanced soft-tissue sarcomas
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information
